• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of Congressional requests received in the month

Dictionary: The Office of the Center Director (OCD) is responsible for answering the Congress’s questions about the work done by CTP. Congressional correspondences include: general information requests, constituent related requests, letters expressing concerns from Congress, questions for the record related to hearings, briefing requests, and document requests. OCD’s goal is to respond to all Congressional and letter correspondence in a timely manner. OCD and the Office of Legislation established a Memorandum of Understanding (MOU) that outlines targets for responding to Congressional requests and inquiries.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A3
Nov 2011N/A5
Dec 2011N/ATBD
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 YTD: 8

Total number of Congressional correspondence received in the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A3
Nov 2011N/A5
Dec 2011N/ATBD
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 YTD: 8

Total number of Congressional briefing requests received in the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A0
Nov 2011N/A0
Dec 2011N/ATBD
Jan 2012N/ATBD
Feb 2012N/ATBD
Mar 2012N/ATBD
Apr 2012N/ATBD
May 2012N/ATBD
Jun 2012N/ATBD
Jul 2012N/ATBD
Aug 2012N/ATBD
Sep 2012N/ATBD

FY 2012 YTD: 0

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.